Xoft
- Company typePrivate
- Founded1998
- HeadquartersSan Jose, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Xoft firmographics
Firmographics- Name
- Xoft
- Legal name
- Elekta
- Website
- https://xoftinc.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Xoft industry classification
Industry- Product category
- Radiation Therapy Equipment
- NAICS
- Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Radiation Oncology (HLAKAFAC)
- akta.pro secondary industries
- Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC), Radiation Safety, Dosimetry & Regulatory Compliance (Nuclear Medicine) (HLAIAGAJ)
Keywords
Where Xoft is headquartered
LocationHeadquarters
- HQ city
- San Jose
- HQ country
- United States
- HQ region
- North America
Markets served
Xoft business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Medical Device Hardware Sales: Sale of Elekta Xoft Axxent Electronic Brachytherapy System and associated applicators including balloon, surface, vaginal, and cervical applicators. One-time capital equipment sale with accompanying consumables and accessories.
- Service and Support Contracts: Ongoing maintenance, support, and service contracts through Elekta Care platform for installed base of Xoft systems.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Xoft product offering
Product offeringCore offering
Xoft designs and manufactures the Elekta Xoft Axxent Electronic Brachytherapy (eBx) System, a portable radiation therapy device that uses a 50 kV miniaturized X-ray source to deliver low-energy, high-dose-rate localized radiation for breast, skin, and gynecological cancers. The system is supported by a family of applicators (balloon, surface, vaginal, cervical) and shielding accessories that allow treatment in standard outpatient rooms and operating theaters without dedicated bunker infrastructure.
Product overview
Elekta Xoft is an electronic brachytherapy (eBx) platform consisting of the Axxent Electronic Brachytherapy System as the core product, complemented by a range of applicators (Balloon, Surface, Vaginal, and Cervical), shielding accessories (FlexiShield and Rigid Shield), and supporting components (Controller, Physics Accessories Kit, and Hub). The system delivers low-energy (50 kV) high dose rate radiation therapy using a miniaturized X-ray source for multiple clinical indications including early-stage breast cancer, non-melanoma skin cancer (NMSC), and gynecological cancers, as well as intraoperative radiation therapy (IORT) applications. The platform is designed for portability and accessibility, requiring no bunker or dedicated shielding, allowing treatment in various clinical settings from standard outpatient rooms to operating theaters.
Differentiator
Problem solved
Functional benefit
Brands
- Xoft Axxent Electronic Brachytherapy (eBx) System: Portable electronic brachytherapy system for cancer treatment requiring no bunker or dedicated shielding, using a 50 kV miniaturized X-ray source for low energy, high dose rate localized radiation therapy.
Products and services
- Elekta Xoft Axxent Electronic Brachytherapy (eBx) System
- Xoft Controller
- Xoft Balloon Applicator
- Xoft Surface Applicator
- Xoft Vaginal Applicator
- Xoft Cervical Applicator
- FlexiShield
- Rigid Shield
- Physics Accessories Kit
- Xoft Hub
- Breast eBx
- Skin eBx
- GYN eBx
Quantifiable outcome
- Market projected to double from USD 60 million to USD 120 million by 2030
Companies that use Xoft
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles1 record
Xoft technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Xoft partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor.
- Martin Health SystemminorCase study customer using Elekta Xoft for electronic brachytherapy treatment at Stuart, FL location. Demonstrates real-world implementation and clinical outcomes.
- Monash Cancer CentreminorCase study customer in Victoria, Australia using Elekta Xoft for cancer treatment. Demonstrates international adoption of the technology.
- Lutheran HospitalminorCase study customer at Fort Wayne, IN using Elekta Xoft for electronic brachytherapy treatments.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
Xoft competitors and assessment
Company assessmentDirect peers
- Varian Medical Systems (Siemens Healthineers): Varian is the largest global competitor in radiation oncology and brachytherapy, offering HDR afterloaders (e.g., Bravos/Gammamed), applicators, and treatment planning software that compete head-to-head with Xoft's eBx system across breast, skin, and GYN indications.
- Elekta Flexitron / Venezia / Geneva (brachytherapy line): Within the same parent company, Elekta's Flexitron HDR afterloader and Venezia/Geneva GYN applicators are the primary competing brachytherapy modalities for the same clinical indications Xoft targets, and compete for internal R&D and commercial attention.
- IntraOp Medical: IntraOp manufactures the Mobetron intraoperative electron-beam radiation therapy (IOERT) system used in IORT workflows that directly overlap with Xoft's breast IORT use case at cancer surgery centers.
- Sensus Healthcare: Sensus Healthcare sells the SRT-100 superficial radiation therapy system for non-melanoma skin cancer, directly competing with Xoft's Skin eBx indication and targeting the same dermatology and oncology office-based setting.
- iCAD (Xoft skin brachytherapy): iCAD previously owned and commercialized the original Xoft Axxent electronic brachytherapy system before the Elekta acquisition and remains active in X-ray-based brachytherapy, making it a direct eBx peer.
Broad incumbents
- Carl Zeiss Meditec: ZEISS offers the INTRABEAM single-channel intraoperative radiotherapy system for IORT, which is the closest direct technical comparator to Xoft's eBx in breast and other surgical oncology workflows.
- Accuray: Accuray sells CyberKnife and TomoTherapy radiation therapy systems that compete for cancer-center capex and patient share against Xoft's brachytherapy solutions in adjacent oncology indications.
Emerging players
- RefleXion Medical: RefleXion develops biology-guided radiotherapy (BgRT) and PET-guided treatment systems that represent an emerging external-beam alternative for cancer indications currently addressed by Xoft's brachytherapy products.
- ViewRay: ViewRay's MRIdian MR-guided radiation therapy system competes for the same hospital capital equipment budgets and oncology patient referrals targeted by Xoft's eBx platform.
Others
- Elekta Kaiku Health (life sciences): Elekta's life sciences digital health portfolio sits within the same parent company and represents an enabling software/patient engagement layer that could integrate with Xoft eBx workflows to enhance outcomes tracking and value-based reimbursement positioning.
Market position
Strengths2 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Xoft social profiles
Digital presenceXoft financial estimates
Financial estimateRevenue estimate
Valuation estimate
Xoft leadership team
Management profileNumber of profiles
Profiles1 record
Xoft funding detail
Funding detailFunding overview
Funding rounds8 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Xoft M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Xoft
What does Xoft do?
Xoft designs and manufactures the Elekta Xoft Axxent Electronic Brachytherapy (eBx) System, a portable radiation therapy device that uses a 50 kV miniaturized X-ray source to deliver low-energy, high-dose-rate localized radiation for breast, skin, and gynecological cancers. The system is supported by a family of applicators (balloon, surface, vaginal, cervical) and shielding accessories that allow treatment in standard outpatient rooms and operating theaters without dedicated bunker infrastructure.
Is Xoft a public or private company?
Xoft is a private company. It is classified as corporate owned and is currently operating.
When was Xoft founded?
Xoft was founded in 1998. It employs 51 to 100 people.
Where is Xoft based?
Xoft is headquartered in San Jose, United States, in the North America region.
How does Xoft make money?
Two revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are service and Support Contracts.
Who are Xoft's main competitors?
Direct peers on record are Varian Medical Systems (Siemens Healthineers), Elekta Flexitron / Venezia / Geneva (brachytherapy line), IntraOp Medical, Sensus Healthcare and iCAD (Xoft skin brachytherapy). Broad incumbents are Carl Zeiss Meditec and Accuray. Emerging players are RefleXion Medical and ViewRay. Elekta Kaiku Health (life sciences) is listed as an others.
Does Xoft have an API?
No public API is recorded for Xoft.
What industry is Xoft in?
Xoft's product category is Radiation Therapy Equipment. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology, with a secondary code of HLAHADAC, Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser). Its NAICS code is 334517 and its SIC code is 3844.